UA91282U - Drug formulation possessing pronounced antigestagenic activity - Google Patents

Drug formulation possessing pronounced antigestagenic activity

Info

Publication number
UA91282U
UA91282U UAU201401314U UAU201401314U UA91282U UA 91282 U UA91282 U UA 91282U UA U201401314 U UAU201401314 U UA U201401314U UA U201401314 U UAU201401314 U UA U201401314U UA 91282 U UA91282 U UA 91282U
Authority
UA
Ukraine
Prior art keywords
drug formulation
antigestagenic activity
formulation possessing
pronounced antigestagenic
possessing pronounced
Prior art date
Application number
UAU201401314U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ніколай Борісовіч Сорокін
Original Assignee
Ніколай Борісовіч Сорокін
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ніколай Борісовіч Сорокін filed Critical Ніколай Борісовіч Сорокін
Priority to UAU201401314U priority Critical patent/UA91282U/en
Publication of UA91282U publication Critical patent/UA91282U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A drug formulation containing one or more packed dosage units of the Mifepriston-based pharmaceutical composition possessing the pronounced antigestagenic activity contains the active ingredient (10-200 mg per dosage unit) and the excipients, namely filling agent, disintegrating agent, the lubricant (0.9-1.5 mass %), and the binding agent.
UAU201401314U 2014-02-10 2014-02-10 Drug formulation possessing pronounced antigestagenic activity UA91282U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201401314U UA91282U (en) 2014-02-10 2014-02-10 Drug formulation possessing pronounced antigestagenic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201401314U UA91282U (en) 2014-02-10 2014-02-10 Drug formulation possessing pronounced antigestagenic activity

Publications (1)

Publication Number Publication Date
UA91282U true UA91282U (en) 2014-06-25

Family

ID=56283040

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201401314U UA91282U (en) 2014-02-10 2014-02-10 Drug formulation possessing pronounced antigestagenic activity

Country Status (1)

Country Link
UA (1) UA91282U (en)

Similar Documents

Publication Publication Date Title
PH12017502431A1 (en) Pharmaceutical formulations comprising tenofovir and emtrictabine
MX2016016593A (en) Novel aminoalkyl benzothiazepine derivative and use thereof.
MX2017004772A (en) Compositions and methods for physiological delivery using cannabidiol.
MX2017016802A (en) Pharmaceutical formulations.
PH12018502738A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
MX2017003561A (en) Compositions and methods for cannabinoid coatings for use in drug delivery.
MX2018000546A (en) Pharmaceutical composition containing celecoxib and tramadol.
PH12020550815A1 (en) Delayed release deferiprone tablets and methods of using the same
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2018012618A (en) Oral pharmaceutical compositions of mesalazine.
MX2017013636A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from different particles.
PH12019500154A1 (en) Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof
MX2022007391A (en) Compounds active towards nuclear receptors.
MX2022007265A (en) Compounds active towards nuclear receptors.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2017005163A (en) Onapristone extended-release compositions and methods.
WO2019004788A3 (en) Pharmaceutical composition containing broussochalcone a as active ingredient for prevention or treatment of inflammatory bowel disease
MX2019008338A (en) Pharmaceutical composition containing sulglycotide or pharmaceutically acceptable salt thereof for preventing or treating dry eye.
MX2017013633A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles.
WO2017064652A3 (en) Low dose oral dipyridamole compositions and uses thereof
MX2018010065A (en) Oral dosage form comprising rifaximin in form beta.
MX2017013643A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix.
UA91282U (en) Drug formulation possessing pronounced antigestagenic activity
MX2020006886A (en) Drug delivery system.